The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis
- PMID: 31592079
- PMCID: PMC6771034
The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis
Abstract
Despite advances in medical care, the prevalence and mortality associated with cirrhosis continue to rise. The majority of medical care and physician efforts are devoted to the management of decompensated cirrhosis and its complications of gastrointestinal hemorrhage, hepatic encephalopathy, and ascites; however, limited efforts are placed on the medical management of compensated cirrhosis. Patients with compensated cirrhosis carry a higher survival rate, and, when diagnosed early, may be screened for future decompensation. When possible, these patients can be treated for their underlying disease to prevent disease progression and avoid the need for liver transplantation. This article reviews the importance of early diagnosis, outpatient management of compensated cirrhosis, early screening for potential decompensation, and patient education.
Keywords: Compensated cirrhosis; gastroesophageal varices; hepatocellular carcinoma; malnutrition; patient education; polypharmacy.
Copyright © 2019, Gastro-Hep Communications, Inc.
Conflict of interest statement
The authors have no relevant conflicts of interest to disclose.
Figures



Similar articles
-
British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis - part 1: compensated cirrhosis.Frontline Gastroenterol. 2023 Jul 28;14(6):453-461. doi: 10.1136/flgastro-2023-102430. eCollection 2023. Frontline Gastroenterol. 2023. PMID: 37862444 Free PMC article.
-
The portal hypertension syndrome: etiology, classification, relevance, and animal models.Hepatol Int. 2018 Feb;12(Suppl 1):1-10. doi: 10.1007/s12072-017-9827-9. Epub 2017 Oct 24. Hepatol Int. 2018. PMID: 29064029 Review.
-
[Management of compensated liver cirrhosis 2018 - Evidence based prophylactic measures].Z Gastroenterol. 2018 Jan;56(1):55-69. doi: 10.1055/s-0043-124000. Epub 2018 Jan 9. Z Gastroenterol. 2018. PMID: 29316579 Review. German.
-
[Management of patients with decompensated liver cirrhosis].Rev Prat. 2017 Sep;67(7):735-739. Rev Prat. 2017. PMID: 30512767 French.
-
Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Am J Gastroenterol. 2009 Jul;104(7):1802-29. doi: 10.1038/ajg.2009.191. Epub 2009 May 19. Am J Gastroenterol. 2009. PMID: 19455106 Review.
Cited by
-
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.Mol Cell Proteomics. 2024 Dec;23(12):100876. doi: 10.1016/j.mcpro.2024.100876. Epub 2024 Nov 8. Mol Cell Proteomics. 2024. PMID: 39521382 Free PMC article.
-
Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.bioRxiv [Preprint]. 2024 Jun 19:2024.06.19.599662. doi: 10.1101/2024.06.19.599662. bioRxiv. 2024. Update in: Mol Cell Proteomics. 2024 Dec;23(12):100876. doi: 10.1016/j.mcpro.2024.100876. PMID: 38948836 Free PMC article. Updated. Preprint.
-
Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study.Ann Surg Oncol. 2021 Apr;28(4):1929-1936. doi: 10.1245/s10434-020-09156-4. Epub 2020 Sep 25. Ann Surg Oncol. 2021. PMID: 32975686 Free PMC article.
-
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments.World J Gastroenterol. 2023 Aug 28;29(32):4831-4850. doi: 10.3748/wjg.v29.i32.4831. World J Gastroenterol. 2023. PMID: 37701135 Free PMC article. Review.
-
Cutoff Values for Serum Ferritin in Predicting Cirrhosis Severity due to Cholestatic Jaundice in Vietnamese Children.Med Arch. 2022 Apr;76(2):122-126. doi: 10.5455/medarh.2022.76.122-126. Med Arch. 2022. PMID: 35774043 Free PMC article.
References
-
- Heron M. Deaths: leading causes for 2016. Natl Vital Stat Rep. 2018;67(6):1–77. - PubMed
-
- Allen AM, Kim WR, Moriarty JP, Shah ND, Larson JJ, Kamath PS. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016;64(6):2165–2172. - PubMed
-
- Rinella ME, Sanyal AJ. Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol. 2016;13(4):196–205. - PubMed
-
- Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53(3):726–736. - PubMed
LinkOut - more resources
Full Text Sources
Medical